Ultragenyx Pharmaceutical
RARE
RARE
227 hedge funds and large institutions have $2.76B invested in Ultragenyx Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 77 reducing their positions, and 25 closing their positions.
Holders
227
Holders Change
+2
Holders Change %
+0.89%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
31
Increased
88
Reduced
77
Closed
25
Calls
$9.19M
Puts
$10.4M
Net Calls
-$1.23M
Net Calls Change
-$3.51M
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$55.6M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$36.3M |
| 3 |
3
BlackRock
New York
|
$195M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$271M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$22.4M |
